CELUW
Celularity IncNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
$-0.87
Beta
0.48
52W High
$0.06
52W Low
$0.00
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Celularity Inc
Celularity Inc (CELUW) is a pioneering clinical-stage biotechnology firm dedicated to developing innovative cell therapies that harness the regenerative capabilities of human placental cells. The company strategically targets pressing health challenges such as cancer, autoimmune disorders, and degenerative diseases, facilitating the creation of off-the-shelf therapies that enhance patient accessibility. With a promising pipeline supported by a substantial portfolio of intellectual property, Celularity is well-positioned within the rapidly evolving cell-based medicine sector, meeting the growing demand for transformative therapeutic solutions in areas of substantial unmet medical need.
Fundamentals
| Revenue (TTM) | $26.55M |
| Gross Profit (TTM) | $6.48M |
| EBITDA | $-54.01M |
| Operating Margin | -492.10% |
| Return on Equity | -6367.00% |
| Return on Assets | -30.90% |
| Revenue/Share (TTM) | $1.04 |
| Book Value | $-1.32 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -61.30% |
| Quarterly Revenue Growth (YoY) | -77.40% |
| Shares Outstanding | 0 |
| Float | $18.87M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
138.49%
HV 20-Day
123.21%
HV 30-Day
126.93%
HV 60-Day
139.38%
HV Rank
—
Volatility is currently expanding
Data last updated: 6/15/2026